Angela Kaczorowski-Worthley

Angela Kaczorowski-Worthley

Auto-generated profile, based on publicly available information

Angela Kaczorowski-Worthley

Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, KS, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in iScience
Verified
Journal Article
Open access
SMScott Matson
Scott Matson
LNLinh T. Ngo
Linh T. Ngo
YSYui Sugawara
Yui Sugawara
Veani Roshale FernandoVeani Roshale Fernando
Veani Roshale Fernando
CLClaudia Lugo
Claudia Lugo
MDM. Kristen Demoruelle
M. Kristen Demoruelle
Idiopathic pulmonary fibrosis (IPF) causes progressive respiratory failure with variable survival trajectories among patients. Neutrophils accumulate in IPF lungs, but their mechanistic contribution to disease progression remains to be determined. We applied label-free quantitative proteomics to IPF lung tissue (n = 10) and bronchoalveolar lavage fluid (BALF) (n = 50) from patients with distinct survival outcomes. Neutrophil degranulation emerged as the pathway most strongly associated with poor survival in lung tissue and second most significant in BALF. We validated these findings using absolute quantification of neutrophil degranulation markers in two independent IPF cohorts (n = 156 and n = 52). Higher BALF levels of extracellular DNA, DNA-myeloperoxidase complexes, calprotectin, and neutrophil elastase predicted worse survival (hazard ratios: 1.79–2.19) and correlated with reduced lung function. These results identify neutrophil degranulation as a compartment-specific mechanism of lung injury in IPF that may guide therapeutic development and risk stratification.

25 March 2025 in CHEST Pulmonary
Verified
Journal Article
Open access
AKAngela Kaczorowski-Worthley
Angela Kaczorowski-Worthley
DMDinesh Pal Mudaranthakam
Dinesh Pal Mudaranthakam
JRJanell Reichuber
Janell Reichuber
CSChris Streiler
Chris Streiler
SPSahil Pandya
Sahil Pandya
SMScott Matson
Scott Matson
Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) portends a devastating prognosis for patients, with survival typically being < 5 to 8 years after diagnosis. Limited clinical trial data exist to guide treatment strategies, and the efficacy of current strategies-immunomodulation and antifibrotics-remains uncertain. Large randomized controlled trials are costly, but pragmatic trial designs could reduce expenses. Establishing equipoise and assessing feasibility from both patient and expert perspectives are essential for developing these trials. What are the perceptions of RA-ILD experts and patients with interstitial lung disease surrounding equipoise, feasibility, and trial design? A qualitative study involving a panel of 10 RA-ILD experts and 3 patient panels was conducted. Experts were recruited via snowball sampling, and patient panels included 29 individuals with interstitial lung disease or their caregivers. Discussions were transcribed and analyzed using inductive coding, creating a thematic network based on the Attride-Stirling guidelines. Expert themes included variability in treatment strategies, prioritizing patient-reported outcomes and balancing pragmatism with data collection in trial design. Patient themes highlighted outcomes of importance, participation barriers, and the need for patient-centered research. Both expert and patient panels endorsed using real-world clinical outcomes and patient-reported outcomes as primary trial end points. Pragmatic trials could reduce costs and expand inclusion criteria, highlighting the potential of patient-centered approaches in RA-ILD research.

5 May 2026 in Behavioural Brain Research
Verified
Journal Article
Open access
KSKyle Singerman
Kyle Singerman
AKAngela Kaczorowski-Worthley
Angela Kaczorowski-Worthley
URUma Ramesh
Uma Ramesh
RLRebecca J. Lepping
Rebecca J. Lepping
JFJohn Flynn
John Flynn
Patients with post-paralytic facial synkinesis (PPFS) experience a diverse array of neuronal changes from aberrant peripheral neurogenesis to cortical changes. The aim of this review is to utilize a comprehensive search strategy to (1) identify studies using functional magnetic resonance imaging (fMRI) to evaluate PPFS, and (2) synthesize the available evidence for any unifying structural and functional cortical changes which hold promise for future investigation. A search of Pubmed and Embase databases was conducted with a research librarian. Articles were then screened and reviewed independently by two authors. Inclusion criteria specified studies reporting quantitative imaging evaluation of post-paralytic facial synkinesis. Cerebral cortical changes were evaluated using diffuse tensor imaging, task-based, and resting-state fMRI. Specific assessments of sameness (Dice coefficients), transmission patterns (functional anisotropy), synchronization (Voxel-Mirrored Homotopic Connectivity: VMHC), intrinsic activity (Amplitude of Low Frequency Fluctuations: ALFF), and network efficiency (rich-club nodes) were all examined. Of the 359 studies identified, 13 studies met inclusion criteria. The cortical changes observed included diffuse/overlapping activation patterns, impaired interhemispheric communication, structural brain changes, and structural/functional connectivity mismatch. Evidence of cortical reorganization is apparent in post-paralytic facial synkinesis. Maladaptive neuroplasticity is a hallmark of multiple neuropathologic disorders and should be investigated as a future therapeutic target.

29 April 2026 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
CBCole L. Bird
Cole L. Bird
RARahul Alapati
Rahul Alapati
FMFrank Thomas Materia
Frank Thomas Materia
AKAngela Kaczorowski‐Worthley
Angela Kaczorowski‐Worthley
VBVidur Bhalla
Vidur Bhalla
JOJamie R. Oliver
Jamie R. Oliver